Patients
Health Information
Product Information Request
Our Products
CephalonCares Foundation Patient Assistance Programs
Reimbursement Assistance
Clinical Trials Information
Healthcare Professionals
Therapeutic Focus
Product Information Request
Our Products
CephalonCares Foundation Patient Assistance Programs
Reimbursement Assistance
Clinical Trials Information
Partners
Business Collaboration
Research Partnerships
Investors
Media
Media Resources
Featured Profiles
On The Record
Our Company
Our Story
Awards & Recognition
Our Science
R&D Process
Clinical Trials
Pipeline
Our Responsibility
Business Conduct
Relationships with Healthcare Professionals
CephalonCares Foundation
Commitment to Community
Careers
Contact Us
Websites
Terms of Use
Privacy
Home
Contact Us
Websites
CephalonCares Foundation
Sitemap
Our Company
Our Science
Our Responsibility
Careers
Patients
Healthcare Professionals
Partners
Investors
Media
Search Site
Search
Media
News Releases
Media Resources
Corporate
Central Nervous System Disorders
Cancer
Pain
Featured Profiles
Healthcare Professionals
Margaret Hansen Frogge, RN, MS
Michael Thorpy, M.D.
Programs
Frank Baldino, Jr. Endowed Scholarship Fund
Cephalon Helps to Launch Framing Life With Lymphoma
When Good Medicines Become Bad Drugs
Cephalon to Match Employee Contributions to Aid Earthquake Relief in Haiti
The Leukemia & Lymphoma Society Partnership - Light The Night
Oncology Nursing Society Foundation Partnership
National Organization for Rare Disorders Partnership
Community Volunteers in Medicine
The Franklin-Cephalon Partnership
Federation of State Medical Boards
The Partnership for a Drug-Free America
Horst Witzel Award
National Constitution Center Partnership
Products
Malaria
On The Record
Cephalon Response to March 18, 2009, JAMA Article "The Effects of Modafinil on Dopamine and Dopamine Transporters In the Male Human Brain"
Q&A on Settlements Regarding Investigations into Cephalon Business Practices
Archive
2009 PhRMA Code on Interactions with Healthcare Professionals
Opioids Cephalon Applying Drug Delivery Expertise Toward Development of Tamper-Deterrent Formulation of Extended-Release Opioids
Home
>
Media
>
News Releases
News Releases
2011
|
2010
|
2009
|
2008
|
2007
|
2006
|
2005
|
2004
<< back
Click here to read the full press release.
Loading...